These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
450 related articles for article (PubMed ID: 16084575)
1. Germline mutations of BRCA1 and BRCA2 in Korean sporadic ovarian carcinoma. Kim YT; Nam EJ; Yoon BS; Kim SW; Kim SH; Kim JH; Kim HK; Koo JS; Kim JW Gynecol Oncol; 2005 Dec; 99(3):585-90. PubMed ID: 16084575 [TBL] [Abstract][Full Text] [Related]
2. Germline mutations of BRCA1 and BRCA2 in Korean breast and/or ovarian cancer families. Kang HC; Kim IJ; Park JH; Kwon HJ; Won YJ; Heo SC; Lee SY; Kim KH; Shin Y; Noh DY; Yang DH; Choe KJ; Lee BH; King SB; Park JG Hum Mutat; 2002 Sep; 20(3):235. PubMed ID: 12204006 [TBL] [Abstract][Full Text] [Related]
3. BRCA1 and BRCA2 germline mutations in Korean patients with sporadic breast cancer. Seo JH; Cho DY; Ahn SH; Yoon KS; Kang CS; Cho HM; Lee HS; Choe JJ; Choi CW; Kim BS; Shin SW; Kim YH; Kim JS; Son GS; Lee JB; Koo BH Hum Mutat; 2004 Oct; 24(4):350. PubMed ID: 15365993 [TBL] [Abstract][Full Text] [Related]
4. Mutational analysis of BRCA1 and BRCA2 genes in Chinese ovarian cancer identifies 6 novel germline mutations. Khoo US; Ngan HY; Cheung AN; Chan KY; Lu J; Chan VW; Lau S; Andrulis IL; Ozcelik H Hum Mutat; 2000 Jul; 16(1):88-9. PubMed ID: 10874312 [TBL] [Abstract][Full Text] [Related]
5. High frequency of BRCA1/2 germline mutations in consecutive ovarian cancer patients in Poland. Brozek I; Ochman K; Debniak J; Morzuch L; Ratajska M; Stepnowska M; Stukan M; Emerich J; Limon J Gynecol Oncol; 2008 Feb; 108(2):433-7. PubMed ID: 17997147 [TBL] [Abstract][Full Text] [Related]
6. Germline mutations in the BRCA1 and BRCA2 genes in Turkish breast/ovarian cancer patients. Manguoglu AE; Lüleci G; Ozçelik T; Colak T; Schayek H; Akaydin M; Friedman E Hum Mutat; 2003 Apr; 21(4):444-5. PubMed ID: 12655560 [TBL] [Abstract][Full Text] [Related]
7. BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy. Ottini L; Masala G; D'Amico C; Mancini B; Saieva C; Aceto G; Gestri D; Vezzosi V; Falchetti M; De Marco M; Paglierani M; Cama A; Bianchi S; Mariani-Costantini R; Palli D Cancer Res; 2003 Jan; 63(2):342-7. PubMed ID: 12543786 [TBL] [Abstract][Full Text] [Related]
8. BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases. Pal T; Permuth-Wey J; Betts JA; Krischer JP; Fiorica J; Arango H; LaPolla J; Hoffman M; Martino MA; Wakeley K; Wilbanks G; Nicosia S; Cantor A; Sutphen R Cancer; 2005 Dec; 104(12):2807-16. PubMed ID: 16284991 [TBL] [Abstract][Full Text] [Related]
9. Contribution of BRCA1 and BRCA2 to familial ovarian cancer: a gynecologic oncology group study. Reedy M; Gallion H; Fowler JM; Kryscio R; Smith SA Gynecol Oncol; 2002 May; 85(2):255-9. PubMed ID: 11972384 [TBL] [Abstract][Full Text] [Related]
10. BRCA1 germline mutations and polymorphisms in a clinic-based series of ovarian cancer cases: a Gynecologic Oncology Group study. Smith SA; Richards WE; Caito K; Hanjani P; Markman M; DeGeest K; Gallion HH Gynecol Oncol; 2001 Dec; 83(3):586-92. PubMed ID: 11733976 [TBL] [Abstract][Full Text] [Related]
11. Ovarian cancer associated with inherited mutations in BRCA1 or BRCA2. Swisher E Curr Womens Health Rep; 2003 Feb; 3(1):27-32. PubMed ID: 12521547 [TBL] [Abstract][Full Text] [Related]
12. Identification of germline BRCA1 and BRCA2 genetic alterations in Greek breast cancer moderate-risk and low-risk individuals--correlation with clinicopathological data. Kataki A; Gomatos I; Pararas N; Armakolas A; Panousopoulos D; Karantzikos G; Voros D; Zografos G; Markopoulos C; Leandros E; Konstadoulakis M Clin Genet; 2005 Apr; 67(4):322-9. PubMed ID: 15733268 [TBL] [Abstract][Full Text] [Related]
13. Mutation analysis of BRCA1 and BRCA2 from 793 Korean patients with sporadic breast cancer. Han SH; Lee KR; Lee DG; Kim BY; Lee KE; Chung WS Clin Genet; 2006 Dec; 70(6):496-501. PubMed ID: 17100994 [TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in BRCA1 and BRCA2 and risk of epithelial ovarian cancer. Wenham RM; Schildkraut JM; McLean K; Calingaert B; Bentley RC; Marks J; Berchuck A Clin Cancer Res; 2003 Oct; 9(12):4396-403. PubMed ID: 14555511 [TBL] [Abstract][Full Text] [Related]
16. BRCA1 and BRCA2 mutation prevalence and clinical characteristics of a population-based series of ovarian cancer cases from Denmark. Soegaard M; Kjaer SK; Cox M; Wozniak E; Høgdall E; Høgdall C; Blaakaer J; Jacobs IJ; Gayther SA; Ramus SJ Clin Cancer Res; 2008 Jun; 14(12):3761-7. PubMed ID: 18559594 [TBL] [Abstract][Full Text] [Related]
17. Novel germline BRCA1 and BRCA2 mutations in Turkish women with breast and/or ovarian cancer and their relatives. Egeli U; Cecener G; Tunca B; Tasdelen I Cancer Invest; 2006; 24(5):484-91. PubMed ID: 16939956 [TBL] [Abstract][Full Text] [Related]
18. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1. Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ; J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670 [TBL] [Abstract][Full Text] [Related]
19. Mutational analysis of BRCA1 and BRCA2 and clinicopathologic analysis of ovarian cancer in 82 ovarian cancer families: two common founder mutations of BRCA1 in Japanese population. Sekine M; Nagata H; Tsuji S; Hirai Y; Fujimoto S; Hatae M; Kobayashi I; Fujii T; Nagata I; Ushijima K; Obata K; Suzuki M; Yoshinaga M; Umesaki N; Satoh S; Enomoto T; Motoyama S; Tanaka K; Clin Cancer Res; 2001 Oct; 7(10):3144-50. PubMed ID: 11595708 [TBL] [Abstract][Full Text] [Related]
20. Incidence of BRCA1 and BRCA2 mutations in young Korean breast cancer patients. Choi DH; Lee MH; Bale AE; Carter D; Haffty BG J Clin Oncol; 2004 May; 22(9):1638-45. PubMed ID: 15117986 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]